MedTrace Logo

Hyperlactatemia During and After Tumorcraniotomy

NCT04410315 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2022-08-17

No results posted yet for this study

Summary

This study aims to investigate the association between hyperlactatemia and neurological disability, length-of-stay and mortality in patients who undergo tumorcraniotomy. The risk factors that induce lactat accumulation will also be explored.

Conditions

Interventions

OTHER

Serum-lactate < 2,2 mmol/L

Bloodgas analysis every hour from start surgery until recovery ward discharge

OTHER

Serum-lactate >/= 2,2 mmol/L

Bloodgas analysis every hour from start surgery until recovery ward discharge

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-28
Primary Completion
2022-02-18
Completion
2022-02-18

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04410315 on ClinicalTrials.gov